Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoidsONCOGENEIF7.32023-11-209OAAI
Type 2 Deiodinase Thr92Ala Polymorphism Is Not Associated with Cognitive Impairment in Older Adults: A Cross-Sectional StudyMETABOLITESIF3.72022-04-211OAAI
The tissue expression pattern of CA 19.9 is associated with oncological features in medullary thyroid carcinomaENDOCRINEIF2.92020-06-134PREAI
Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectivesENDOCRINE-RELATED CANCERIF4.62019-08-01108OA
MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinomaENDOCRINE-RELATED CANCERIF4.62016-03-0131OAAI
Role of RET genetic variants in MEN2-associated pheochromocytomaEUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22014-06-0131OAAI
Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness (vol 166, pg 847, 2012)EUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22012-06-010OAAI
Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressivenessEUROPEAN JOURNAL OF ENDOCRINOLOGYIF5.22012-02-1732OAAI
The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinomaENDOCRINE-RELATED CANCERIF4.62010-12-0133OAAI